December 20, 1995 Chris D. McKinney, PH. D. Director, Office of Technology Licensing 186 Grinter Hall Gainesville, FL 32611-2037 AMENDMENT NUMBER ONE Re: Oxalate Patent Licenses between UFRFI and Ixion Dear Chris: I refer to the Patent License...Patent License Agreement • December 10th, 1997 • Ixion Biotechnology Inc • Pharmaceutical preparations
PREAMBLELicensing Agreement • December 10th, 1997 • Ixion Biotechnology Inc • Pharmaceutical preparations • Florida
NOTE: Certain portions of this document have been omitted based on a request for confidential treatment. The non-public information has been filed with the Securities and Exchange Commission. Omitted portions are designated with asterisks ("*")....Patent License Agreement • December 10th, 1997 • Ixion Biotechnology Inc • Pharmaceutical preparations
NOTE: Certain portions of this document have been omitted based on a request for confidential treatment. The non-public information has been filed with the Securities and Exchange Commission. Omitted portions are designated with asterisks ("*")....Sponsored Research Agreement • December 10th, 1997 • Ixion Biotechnology Inc • Pharmaceutical preparations • Massachusetts
NOTE: Certain portions of this document have been omitted based on a request for confidential treatment. The non-public information has been filed with the Securities and Exchange Commission. Omitted portions are designated with asterisks ("*"). This...License Agreement • December 10th, 1997 • Ixion Biotechnology Inc • Pharmaceutical preparations
NOTE: Certain portions of this document have been omitted based on a request for confidential treatment. The non-public information has been filed with the Securities and Exchange Commission. Omitted portions are designated with asterisks ("*"). This...License Agreement • December 10th, 1997 • Ixion Biotechnology Inc • Pharmaceutical preparations
